Catalyst
Monitor the outcomes of the study, particularly the impact on anxiety and communication, as well as any subsequent adoption of the tool in clinical practice.
Date
July 1, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.